India  

Pfizer’s COVID Booster Shot for 5 to 11 Year Olds Authorized by FDA

Video Credit: Wibbitz Top Stories - Duration: 01:30s - Published
Pfizer’s COVID Booster Shot for 5 to 11 Year Olds Authorized by FDA

Pfizer’s COVID Booster Shot for 5 to 11 Year Olds Authorized by FDA

Pfizer’s COVID Booster Shot , for 5 to 11 Year Olds, Authorized by FDA.

NBC News reports on May 17, the Food and Drug Administration (FDA)... … announced it had authorized Pfizer-BioNTech's coronavirus booster dose for 5 to 11 year olds.

The FDA says eligible recipients of a booster dose could receive the extra shot starting five months after their initial two-dose series.

Per NBC News, Pfizer's booster shot for 5 to 11 year olds is 10 micrograms ... .

... a third of the dosage given to citizens 12 and older.

Following the FDA's ruling, it is now up to the Centers for Disease Control and Prevention (CDC) to recommend how to implement boosters for the age group.

CDC data shows less than one third of 5 to 11 year olds in the United States have recieved the primary series of a COVID-19 vaccine.

Experts say booster shots offer better protection against the omicron strain and its associated subvariants.

The CDC's Advisory Committee on Immunization Practices will reportedly discuss booster shots on May 19.

Dr. Rochelle Walensky, the Director of the CDC, should have her final recommendation following the committee's discussion


You Might Like


💡 newsR Knowledge: Other News Mentions

Food and Drug Administration Food and Drug Administration Agency of the US Department of Health and Human Services

FDA To Pull Juul E-Cigarettes off US Market [Video]

FDA To Pull Juul E-Cigarettes off US Market

FDA To Pull Juul E-Cigarettes , off US Market. Fox News and other outlets report that the Food and Drug Administration (FDA) is gearing up to order Juul Labs Inc. to remove its e-cigarettes from store shelves in America. Fox News and other outlets report that the Food and Drug Administration (FDA) is gearing up to order Juul Labs Inc. to remove its e-cigarettes from store shelves in America. The announcement is expected to come as data presented by Juul has been under review for nearly two years. . The announcement is expected to come as data presented by Juul has been under review for nearly two years. . Fox News reports that four years ago, the vaping company came under fire for its fruity flavors and marketing direction. Fox News reports that four years ago, the vaping company came under fire for its fruity flavors and marketing direction. Fox News reports that four years ago, the vaping company came under fire for its fruity flavors and marketing direction. Critics say underage vaping surged as a result. Juul has since cut back on its marketing, and in 2019, the company stopped selling fruity, sweet cartridge flavors. . Still, sales have dramatically declined for the e-cigarette manufacturer. . The sale of all fruity e-cigarette flavors has since been banned by the FDA. Juul's impending departure would pave the way for Reynolds American Inc. and NJOY Holidings Inc. to corner the tobacco-flavored segment of the e-cigarette market. Juul's impending departure would pave the way for Reynolds American Inc. and NJOY Holidings Inc. to corner the tobacco-flavored segment of the e-cigarette market. Juul's impending departure would pave the way for Reynolds American Inc. and NJOY Holidings Inc. to corner the tobacco-flavored segment of the e-cigarette market. Fox News reports Juul will be able to file an appeal through the FDA, take the matter to court or file a new application with revised products. . Fox News reports Juul will be able to file an appeal through the FDA, take the matter to court or file a new application with revised products.

Credit: Wibbitz Top Stories    Duration: 01:30Published

Juul E-Cigarettes To Be Banned In the U.S., WSJ Report

Juul e-cigarettes will soon be off the shelves, at least according to a report, that states the FDA is planning to ban the product from being sold in the U.S...
TMZ.com
FDA Panel Endorses COVID Vaccines for Children Under 5 [Video]

FDA Panel Endorses COVID Vaccines for Children Under 5

FDA Panel , Endorses COVID Vaccines, for Children Under 5. On June 15, an advisory panel to the United States Food and Drug Administration voted to recommend two COVID-19 vaccines for kids ages 5 and under. Yahoo reports that both Pfizer/BioNTech and Moderna were under review by the panel. . The unanimous FDA panel vote is the first step in what is predicted to be a quick authorization process. According to Yahoo, data from trials shows that both vaccines continue to protect against severe disease, hospitalization and death. According to Yahoo, data from trials shows that both vaccines continue to protect against severe disease, hospitalization and death. Yahoo reports that parents now have two options for how to vaccinate their children. Pfizer's vaccine for kids is delivered in three, three-microgram doses, while Moderna's vaccine is delivered in two shots of a 25-microgram dose. Our robust clinical study shows that three doses can provide protection for the circulating Omicron variant and offers promise for protection against potential future waves of COVID-19, Dr. Bill Gruber, Pfizer's Vaccine Clinical Research and Development head, via Yahoo. Our robust clinical study shows that three doses can provide protection for the circulating Omicron variant and offers promise for protection against potential future waves of COVID-19, Dr. Bill Gruber, Pfizer's Vaccine Clinical Research and Development head, via Yahoo. The committee’s support today is imperative to providing a critical tool for pediatricians, parents, and caregivers who eagerly await an option for children under five, Dr. Bill Gruber, Pfizer's Vaccine Clinical Research and Development head, via Yahoo. Both companies are now awaiting approval from the FDA and the CDC which will hold an advisory committee meeting on the topic over the weekend.

Credit: Wibbitz Top Stories    Duration: 01:30Published
Pfizer's COVID Vaccine for Kids Under 5 Moves Closer to FDA Approval [Video]

Pfizer's COVID Vaccine for Kids Under 5 Moves Closer to FDA Approval

Pfizer's COVID Vaccine for Kids Under 5 , Moves Closer to FDA Approval . Pfizer announced on June 1 that its application to the Food and Drug Administration (FDA) for the vaccine was complete. Pfizer announced on June 1 that its application to the Food and Drug Administration (FDA) for the vaccine was complete. The three-dose vaccine is for children between the ages of six months and five years. Pfizer released a statement detailing the application. Pfizer and BioNTech completed a rolling application to the U.S. Food and Drug Administration (FDA) for emergency use authorization (EUA)... , Pfizer Statement, via ABC News. ... of the 3-µg [microgram] dose of the Pfizer-BioNTech COVID-19 Vaccine.., Pfizer Statement, via ABC News. ... for children 6 months through 4 years of age (also referred to as 6 months to under 5 years of age) on June 1, 2022, Pfizer Statement, via ABC News. Pfizer reported an 80 percent effectiveness rate in children in May. The FDA also released a statement on June 1, confirming that the agency had accepted the Pfizer application. We recognize parents are anxious to have their young children vaccinated against COVID-19... , FDA Statement, via ABC News. ... and while the FDA cannot predict how long its evaluation of the data and information will take, , FDA Statement, via ABC News. ... we will review any EUA request we receive as quickly as possible using a science-based approach, FDA Statement, via ABC News. According to a poll conducted by the Kaiser Family Foundation in April of this year. ... just 18 percent of parents intend to have their children vaccinated once the vaccine is approved. 27 percent of parents stated that they will "definitely not" vaccinate their children against COVID

Credit: Wibbitz Top Stories    Duration: 01:31Published
FDA Warns Viral Avocado Hack Could Make You Sick [Video]

FDA Warns Viral Avocado Hack Could Make You Sick

FDA Warns Viral Avocado Hack , Could Make You Sick. Fox News reports a recent viral kitchen hack intended to keep avocados fresh for increased periods of time could make you sick. The hack involves storing ripe avocados in jars of water. The method has gained traction on social media platforms. After garnering millions of views, the Food and Drug Administration (FDA) has determined the hack to be unsafe. The FDA does not recommend this practice. , FDA spokesperson, via Fox News . The main concern is with the possibility that any residual human pathogens... , FDA spokesperson, via Fox News . ... for example, Listeria monocytogenes, Salmonella spp., etc. – that may be residing on the avocado surface... , FDA spokesperson, via Fox News . ... may potentially multiply during the storage when submerged in water, FDA spokesperson, via Fox News . In a 2016 study, FDA researchers found dangerous bacteria can accumulate on avocado skins, often causing cross-contamination. Rather than submerging avocados in water, the FDA recommends storing them in a cool and dry environment

Credit: Wibbitz Top Stories    Duration: 01:30Published

Pfizer Pfizer American multinational pharmaceutical and biotechnology corporation

Pfizer’s 3-Dose Vaccine 80% Effective Against Omicron Infection for Youngest Children [Video]

Pfizer’s 3-Dose Vaccine 80% Effective Against Omicron Infection for Youngest Children

Pfizer’s 3-Dose Vaccine , 80% Effective Against Omicron, Infection for Youngest Children. ABC News reports new data shows Pfizer's 3-dose vaccine is 80% effective against omicron infections in children five years old and younger. In all age groups, Pfizer's coronavirus vaccine has been less effective against mild breakthrough infections. but has been shown to offer high protection against severe disease and death. Experts say Pfizer's announcement offers reassurance to parents who wish to protect their children against coronavirus. We are pleased that our formulation for the youngest children, which we carefully selected to be one-tenth of the dose strength for adults ... , statement from Albert Bourla, chairman CEO Pfizer, via ABC News. ... was well tolerated and produced a strong immune response. , statement from Albert Bourla, chairman CEO Pfizer, via ABC News. After two years without a vaccine for young children, many pediatricians and parents intend to vaccinate as soon as possible. However, recent polls have shown over 50% of parents feel they need more information before their children receive a COVID-19 shot. Parents should also be aware that this preliminary data will be supplemented by additional data in June ... , Dr. Alok Patel, pediatric hospitalist Stanford Children's Health, via ABC News. ... which will then be thoroughly reviewed by both the FDA and the CDC. , Dr. Alok Patel, pediatric hospitalist Stanford Children's Health, via ABC News

Credit: Wibbitz Top Stories    Duration: 01:30Published
CDC Signs Off on COVID Vaccine Boosters for Kids Ages 5–11 [Video]

CDC Signs Off on COVID Vaccine Boosters for Kids Ages 5–11

CDC Signs Off on COVID Vaccine Boosters , for Kids Ages 5–11. CNN reports that on May 19, the CDC's Advisory Committee on Immunization Practices (ACIP)... . ... voted in support of recommending an additional Pfizer shot for 5- to 11-year-olds who've received their first two doses. The vote was 11-1 with 1 abstention. CNN reports that the FDA authorized the booster dose earlier this week. Children within this age group are advised to wait at least five months after receiving their two-dose regimen before getting a booster shot. CNN reports a fourth dose is recommended for children who are immunocompromised. . According to Pfizer, a trial of 4,500 children ages 5-11 showed Omicron-fighting antibodies were 36 times stronger upon receiving a booster. The company also says no new safety issues were detected. On May 16, the American Academy of Pediatrics reported that COVID cases in U.S. children rose 76% the previous week compared to two weeks prior. CDC Director Dr. Rochelle Walensky gave opening remarks before the ACIP's vote. The sadness I feel for lives lost, the families devastated and the communities changed is steep. We have the tools we need to protect these people from severe disease and prevent any more tragic deaths, Dr. Rochelle Walensky, via opening remarks before the ACIP's vote, via CNN

Credit: Wibbitz Top Stories    Duration: 01:31Published

Rochelle Walensky Rochelle Walensky American medical scientist

CDC Warns of COVID 'Rebound' After Taking Paxlovid [Video]

CDC Warns of COVID 'Rebound' After Taking Paxlovid

CDC Warns of COVID 'Rebound' , After Taking Paxlovid. Paxlovid can be prescribed for those who may have a high risk of being hospitalized with COVID. . But CDC Director Dr. Rochelle Walensky recently revealed that those who take it can have "rebound" symptoms. If you take Paxlovid, you might get symptoms again, Dr. Rochelle Walensky, CDC Director, via CBS News. We haven't yet seen anybody who has returned with symptoms needing to go to the hospital. , Dr. Rochelle Walensky, CDC Director, via CBS News. So, generally, a milder course, Dr. Rochelle Walensky, CDC Director, via CBS News. Dr. Walensky maintains that the drug is useful in preventing COVID illness that requires hospitalization. Data from the CDC shows that Paxlovid prevents death and hospitalization for unvaccinated COVID patients by up to 90 percent. Health officials are unsure as to the cause of COVID rebound in patients who have taken Paxlovid. One health official described their experience with contracting COVID, taking the drug and getting sick again. I was totally shocked. I did not expect that. , Dr. David Ho, Infectious Disease Expert, via CBS News. And that's because I had tested negative six consecutive days, including two PCR, Dr. David Ho, Infectious Disease Expert, via CBS News. In order to prevent infecting others, Dr. Walensky says that those who experience COVID rebound should take standard virus precautions. They should test. They should put their mask back on. , Dr. Rochelle Walensky, CDC Director, via CBS News. And if their test is positive, restart the isolation protocol, Dr. Rochelle Walensky, CDC Director, via CBS News

Credit: Wibbitz Top Stories    Duration: 01:31Published
CDC Says One-Third of Americans Should Be Wearing Masks [Video]

CDC Says One-Third of Americans Should Be Wearing Masks

CDC Says One-Third of Americans , Should Be Wearing Masks. CNN reports that the U.S. Centers for Disease Control and Prevention (CDC) is urging local officials to encourage their constituents to mask up. Currently, over 32% of Americans live in regions experiencing medium to high COVID-19 community levels. Per CDC data, 9% of Americans live in areas with high COVID-19 community levels. 23% of citizens are currently living in areas with a medium amount of coronavirus transmission. We urge local leaders to encourage the use of prevention strategies like masking in public indoor settings and increasing access to testing and to treatment. , Dr. Rochelle Walensky, CDC Director, via CNN. In areas where community levels are high, everyone should be using prevention measures and wearing a mask in public indoor settings. , Dr. Rochelle Walensky, CDC Director, via CNN. As of May 18, nearly 4.25% of counties in the United States have soaring COVID-19 community levels. . As we’re currently seeing a steady rise of cases in parts of the country... , Dr. Rochelle Walensky, CDC Director, via CNN. ... we encourage everyone to use the menu of tools we have today to prevent further infection and severe disease, , Dr. Rochelle Walensky, CDC Director, via CNN. ... including wearing a mask, getting tested, accessing treatments early if infected and getting vaccinated or boosted, Dr. Rochelle Walensky, CDC Director, via CNN

Credit: Wibbitz Top Stories    Duration: 01:30Published
Increase in US COVID Rates Prompts Health Officials to Urge Mask-Wearing in Some Areas [Video]

Increase in US COVID Rates Prompts Health Officials to Urge Mask-Wearing in Some Areas

Increase in US COVID Rates , Prompts Health Officials to Urge Mask-Wearing, in Some Areas. Federal health officials presented an assessment from the White House on May 18. Speaking were Dr. Ashish Jha, the White House COVID response coordinator, . and Dr. Rochelle P. Walensky, the director of the Centers for Disease Control and Prevention (CDC). We urge local leaders to encourage the use of prevention strategies like masking in public indoor settings.., Dr. Rochelle P. Walensky, CDC Director, via 'The New York Times'. ... and increasing access to testing and treatment for individuals, Dr. Rochelle P. Walensky, CDC Director, via 'The New York Times'. The COVID briefing was the first to be conducted from the White House in six weeks. According to federal data, hospital admissions related to COVID have increased by 20 percent over the past week. The Northeastern U.S. has experienced the most dramatic increase in cases. Dr. Jha urged Congress to approve additional COVID aid to address the rising cases and a potential wave in the fall. Experts weighed in, stating that now is a good time to reimplement prevention measures. We’re seeing rising cases and hospitalizations and testing positivity rates; now is not the time to end these flexibilities that allow great access to care, Ashley Thompson, American Hospital Association, via 'The New York Times'. We are not out of the woods yet, Ashley Thompson, American Hospital Association, via 'The New York Times'. We could be entering a period where we have an increased number of cases but a substantially decreased severity of illness, Dr. Michael T. Osterholm, University of Minnesota, via 'The New York Times'. ... so that we see fewer hospitalizations and many fewer deaths, Dr. Michael T. Osterholm, University of Minnesota, via 'The New York Times'

Credit: Wibbitz Top Stories    Duration: 01:30Published

Pfizer–BioNTech COVID-19 vaccine Pfizer–BioNTech COVID-19 vaccine Type of vaccine for humans

Pfizer's First Quarter Profits Blast Past 2022 Forecast [Video]

Pfizer's First Quarter Profits Blast Past 2022 Forecast

Pfizer's First Quarter , Profits Blast Past, 2022 Forecast. ABC reports that Pfizer's COVID-19 vaccine and treatment sales helped propel the pharmaceuticals company beyond Wall Street's first quarter expectations. . Pfizer's coronavirus vaccine Comirnaty raked in over $13 billion in sales for the first quarter. . Pfizer's coronavirus vaccine Comirnaty raked in over $13 billion in sales for the first quarter. . The vaccine has remained Pfizer's top selling product for almost the last year. . The drugmaker's pill treatment Paxloid reportedly added an additional $1.5 billion to the company's sales. . ABC reports that Pfizer's, profits grew 61% , in the first quarter. . On May 3, the company posted a net income of $7.86 billion and first quarter adjusted earnings of $1.62 per share. . The results easily exceeded the $1.49 increase predicted by industry analysts. . Compared to the same time last year, the company's revenue skyrocketed 77% , to reach $25.66 billion. . According to ABC, the drugmaker expects the company's total revenue in 2022 to reach between $98 billion and $102 billion. . Pfizer's COVID vaccine launched late in 2020 and quickly became the company's top selling product by the second quarter of 2021. In December of 2021, Pfizer's stock reached an all-time high of $61.71 per share.

Credit: Wibbitz Top Stories    Duration: 01:31Published

Advisory Committee on Immunization Practices Centers for Disease Control committee


Centers for Disease Control and Prevention Centers for Disease Control and Prevention United States government public health agency

Anthony Fauci Tests Positive for COVID [Video]

Anthony Fauci Tests Positive for COVID

Anthony Fauci, Tests Positive for COVID. The National Institute of Allergy and Infectious Diseases (NIAID) released a statement on Dr. Fauci's positive COVID test on June 15. He is currently experiencing mild symptoms, NIAID, via statement. The statement specified that Fauci "is fully vaccinated and has been boosted twice.". Dr. Fauci's diagnosis was confirmed by a rapid antigen test. He is being treated with Paxlovid. Dr. Fauci is the Chief Medical Advisor to President Joe Biden. He has not recently been in contact with the president. He has not recently been in close contact with President Biden or other senior government officials, NIAID, via statement. The NIAID statement also specified how he will approach the coming days. Dr. Fauci will follow the COVID-19 guidelines of the Centers for Disease Control and Prevention and medical advice from his physician and return to the NIH when he tests negative, NIAID, via statement. Fauci has consistently urged caution when faced with social encounters. Each of us, in our own personal way, has to make an assessment of what risk you’re willing to accept about getting infected, Anthony Fauci, via CNN. He recently declined attendance at the White House Correspondents' Dinner. In general, the risk is low, but I made a personal assessment. I’m 81 years old, and if I get infected, I have a much higher risk, Anthony Fauci, via CNN. Recently, Dr. Fauci revealed that he has not had a day off since the beginning of the pandemic

Credit: Wibbitz Top Stories    Duration: 01:30Published
US To End COVID Testing Requirement for Air Travelers [Video]

US To End COVID Testing Requirement for Air Travelers

US To End , COVID Testing Requirement , for Air Travelers. CNN reports that on June 10, the Biden administration will announce that the CDC will lift the restriction for air travelers entering the country. The change will reportedly go into effect at midnight on June 12. CNN reports that the travel industry had lobbied against the requirement for months. claiming the protocol wasn't necessary anymore "based on the science and data.". It has been in place since January 2021. But since new COVID variants are continuously arising, the CDC will re-examine the decision to end testing in 90 days. Roger Dow, U.S. Travel Association President, commended the decision. Prior to the pandemic, travel was one of our nation's largest industry exports. , Roger Dow, U.S. Travel Association President, via CNN. The lifting of this requirement will enable the industry to lead the way toward a broader U.S. economic and jobs recovery, Roger Dow, U.S. Travel Association President, via CNN

Credit: Wibbitz Top Stories    Duration: 01:30Published
Moderna Says New Booster Shows 'Superior' Omicron Response [Video]

Moderna Says New Booster Shows 'Superior' Omicron Response

Moderna Says New Booster , Shows 'Superior' Omicron Response. NPR reports Moderna claims its most recent vaccine candidate has shown a "superior neutralizing antibody response" when compared to its first vaccine. It is "bivalent," engineered to target two different antigens. Per NPR, Moderna intends to make its newest booster available in fall 2022. We are submitting our preliminary data and analysis to regulators with the hope that the Omicron-containing bivalent booster will be available in the late summer. , Stéphane Bancel, Moderna CEO, via statement. Due to a higher antibody response, Moderna believes its newest vaccine will offer protection that is "more durable over time" against Omicron. Due to a higher antibody response, Moderna believes its newest vaccine will offer protection that is "more durable over time" against Omicron. Moderna officials think their new vaccine could potentially offer protection for one year. As new variants continuously arise, Moderna officials hope the new bivalent vaccine can counter the more contagious strains taking hold in the United States. As new variants continuously arise, Moderna officials hope the new bivalent vaccine can counter the more contagious strains taking hold in the United States. According to the Centers for Disease Control and Prevention (CDC), two new subvariants of Omicron, BA.4 and BA.5, are spreading quickly across the country. Experts say another wave of coronavirus is bound to occur next winter as cold weather drives citizens back indoors

Credit: Wibbitz Top Stories    Duration: 01:30Published
CDC Ramps Up Monkeypox Alert to Level 2 [Video]

CDC Ramps Up Monkeypox Alert to Level 2

CDC Ramps Up Monkeypox Alert , to Level 2 . The Center for Disease Control and Prevention (CDC) raised the level of alert concerning monkeypox on June 6. Known global cases of the virus have exceeded 1,000 across 29 countries. An alert level of three, the highest level, would recommend against travel that is non-essential. The agency is encouraging the public to “practice enhanced precautions” to curb the spread of the virus. New guidance issued from the CDC recommends that individuals avoid close contact with other infected people and infected animals. According to reporting on the new guidance, those with visible skin legions could be more infectious. . According to the World Health Organization, the virus has been circulating undetected for “weeks, months or possibly a couple of years.”. Experts say that the ease of international travel is likely a significant reason as to why the virus has spread. Diseases that were locally spread are now able to make their way across countries and continents much more easily, Professor Eyal Leshem, Sheba Medical Center, via CNBC. Meanwhile, interaction between humans and animals has also amplified. , Professor Eyal Leshem, Sheba Medical Center, via CNBC. Experts also say that climate change has likely played a role in the speed at which the virus has spread. Climate change has forced some animals into closer contact with humans, you will see more of these types of diseases, Professor Eyal Leshem, Sheba Medical Center, via CNBC. Monkeypox infections are considered rare and the threat to the general public remains low. Symptoms of the virus include headache, fever, swelling, back-pain, and muscle ache

Credit: Wibbitz Top Stories    Duration: 01:30Published